{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:03Z","timestamp":1750534803767,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 78-year-old man receiving bicalutamide for prostate cancer was referred for a PSMA PET\/CT scan to evaluate his gradually rising prostate-specific antigen level. The PSMA PET\/CT revealed gynecomastia with radiotracer uptake in bilateral breast parenchyma, a known but rarely reported effect of bicalutamide monotherapy. This scan also demonstrated metastatic progression of his disease in bone and lymph nodes, and he was started on leuprolide injections. Three months after a decrease in his testosterone level, the radiotracer uptake in his breast tissue had resolved, demonstrating that PSMA-avid bicalutamide-induced gynecomastia is reversible.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005084","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T20:01:42Z","timestamp":1708459302000},"page":"e164-e165","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy"],"prefix":"10.1097","volume":"49","author":[{"given":"Miguel","family":"Muniz","sequence":"first","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Childs","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob J.","family":"Orme","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology and Department of Immunology, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","article-title":"Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia","volume":"60","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","year":"2015","journal-title":"Eur Urol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e0136094","DOI":"10.1371\/journal.pone.0136094","article-title":"Gynecomastia in patients with prostate cancer: a systematic review","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11934-018-0796-x","article-title":"Diagnosis and management of gynecomastia for urologists","volume":"19","year":"2018","journal-title":"Curr Urol Rep"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1097\/RLU.0000000000001742","article-title":"False positive uptake in bilateral gynecomastia on 68Ga-PSMA PET\/CT scan","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/RLU.0000000000002086","article-title":"Re: false positive uptake in bilateral gynecomastia on 68Ga-PSMA PET\/CT scan","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.nuclcard.2007.09.007","article-title":"Tc-99m tetrofosmin uptake in a male patient with gynecomastia","volume":"14","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/RLU.0000000000002597","article-title":"Incidental uptake in benign gynecomastia on 68Ga-DOTATATE PET\/CT","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","first-page":"32","article-title":"Radiolabelled PSMA PET\/CT in breast cancer. A systematic review","volume":"23","year":"2020","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/RLU.0000000000001445","article-title":"68Ga-PSMA expression in pseudoangiomatous stromal hyperplasia of the breast","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","year":"2020","journal-title":"Cancer Imaging"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2967\/jnumed.117.198119","article-title":"Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET\/CT","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2017.10.027","article-title":"PSMA-RADS Version 1.0: a step towards standardizing the interpretation and reporting of PSMA\u2013targeted PET imaging studies","volume":"73","year":"2018","journal-title":"Eur Urol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:07:02Z","timestamp":1750532822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005084","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,2,6]]}}}